The bill H.266 aims to enhance protections for 340B covered entities and 340B contract pharmacies, as well as their patients, against discrimination and interference from drug manufacturers, health insurers, pharmacy benefit managers, and other payors. It introduces a new subchapter in Vermont law specifically addressing the 340B Drug Pricing Program, defining key terms such as "340B contract pharmacy," "340B covered entity," and "340B drug." The bill prohibits manufacturers from denying or restricting the acquisition of 340B drugs by contract pharmacies and mandates that health insurers and pharmacy benefit managers cannot reimburse 340B entities at lower rates than non-340B entities or impose additional burdens that could interfere with patient choice.

Additionally, the bill amends existing law to remove certain provisions related to pharmacy benefit managers and their practices concerning 340B covered entities, ensuring that these entities are treated equitably in reimbursement practices. The legislation emphasizes that any discriminatory actions against 340B entities can lead to legal action for damages and establishes that nothing in this subchapter conflicts with federal law. The act is set to take effect upon passage.

Statutes affected:
As Introduced: 18-3631